[DPHARMA] QoQ TTM Result on 30-Jun-2018 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
26-Nov-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2018
Quarter
30-Jun-2018 [#2]
Profit Trend
QoQ- 1.57%
YoY- 25.12%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Revenue 515,849 498,722 495,341 484,882 477,940 467,987 429,767 12.95%
PBT 65,197 59,666 54,833 53,202 52,929 51,796 45,270 27.55%
Tax -13,738 -12,025 -9,793 -9,321 -9,746 -9,696 -5,416 86.09%
NP 51,459 47,641 45,040 43,881 43,183 42,100 39,854 18.59%
-
NP to SH 51,459 47,776 45,277 44,396 43,710 42,492 40,548 17.23%
-
Tax Rate 21.07% 20.15% 17.86% 17.52% 18.41% 18.72% 11.96% -
Total Cost 464,390 451,081 450,301 441,001 434,757 425,887 389,913 12.37%
-
Net Worth 496,410 483,173 501,487 209,983 206,429 479,809 474,230 3.09%
Dividend
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Div 30,674 30,674 20,937 20,937 23,711 23,711 7,085 165.87%
Div Payout % 59.61% 64.21% 46.24% 47.16% 54.25% 55.80% 17.47% -
Equity
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Net Worth 496,410 483,173 501,487 209,983 206,429 479,809 474,230 3.09%
NOSH 661,881 661,881 661,881 650,902 278,959 278,959 278,959 77.98%
Ratio Analysis
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
NP Margin 9.98% 9.55% 9.09% 9.05% 9.04% 9.00% 9.27% -
ROE 10.37% 9.89% 9.03% 21.14% 21.17% 8.86% 8.55% -
Per Share
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
RPS 77.94 75.35 75.07 173.19 171.33 167.76 154.06 -36.53%
EPS 7.77 7.22 6.86 15.86 15.67 15.23 14.54 -34.17%
DPS 4.63 4.63 3.17 7.50 8.50 8.50 2.54 49.27%
NAPS 0.75 0.73 0.76 0.75 0.74 1.72 1.70 -42.07%
Adjusted Per Share Value based on latest NOSH - 650,902
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
RPS 53.59 51.81 51.46 50.37 49.65 48.61 44.64 12.96%
EPS 5.35 4.96 4.70 4.61 4.54 4.41 4.21 17.33%
DPS 3.19 3.19 2.17 2.17 2.46 2.46 0.74 165.10%
NAPS 0.5157 0.5019 0.5209 0.2181 0.2144 0.4984 0.4926 3.10%
Price Multiplier on Financial Quarter End Date
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Date 29/03/19 31/12/18 28/09/18 29/06/18 30/03/18 29/12/17 29/09/17 -
Price 1.28 0.95 1.23 1.30 2.80 2.53 2.20 -
P/RPS 1.64 1.26 1.64 0.75 1.63 1.51 1.43 9.57%
P/EPS 16.46 13.16 17.93 8.20 17.87 16.61 15.14 5.73%
EY 6.07 7.60 5.58 12.20 5.60 6.02 6.61 -5.52%
DY 3.62 4.88 2.58 5.77 3.04 3.36 1.15 114.93%
P/NAPS 1.71 1.30 1.62 1.73 3.78 1.47 1.29 20.69%
Price Multiplier on Announcement Date
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Date 21/05/19 18/02/19 28/11/18 26/11/18 28/05/18 28/02/18 17/11/17 -
Price 1.36 1.03 1.07 1.08 3.35 2.97 2.20 -
P/RPS 1.75 1.37 1.43 0.62 1.96 1.77 1.43 14.42%
P/EPS 17.49 14.27 15.59 6.81 21.38 19.50 15.14 10.10%
EY 5.72 7.01 6.41 14.68 4.68 5.13 6.61 -9.19%
DY 3.41 4.50 2.97 6.94 2.54 2.86 1.15 106.53%
P/NAPS 1.81 1.41 1.41 1.44 4.53 1.73 1.29 25.35%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment